Screening for Atrial Fibrillation in Adults With Abnormal Echocardiogram Results Using Scheduled ECG Monitoring

What this Trial Is About

Researchers are evaluating the use of specific echocardiographic measurements to identify patients at risk for atrial fibrillation AF and to compare the detection rates of scheduled extended ECG monitoring against standard care. The study aims to determine how well these heart ultrasound parameters can guide AF screening and improve early diagnosis. Participants are randomly assigned to either a study group receiving scheduled cardiac rhythm monitoring every 3 months using extended continuous ECG devices or a control group receiving no intervention. The ECG monitoring includes single-lead and 7-day continuous recordings to detect episodes of AF lasting 30 seconds or longer. During the two-year study, participants will undergo regular ECG assessments to detect AF events. Researchers will measure the occurrence of AF through 12-lead ECG or prolonged ECG recordings. Safety and health status will be monitored throughout the trial, with no masking or blinding involved.

AF Screening in Patients With Abnormal Echocardiographic Parameters